AMICUS THERAPEUTICS, INC. Business Operations Contracts & Agreements
21 Contracts & Agreements
- Agency Agreements (1 contract)
- Collaboration Agreements (10)
- Indemnification Agreements (3)
- Supply Agreements (2)
- Termination Agreements (5)
- First Amendment to the Supply and Manufacturing Services Agreement (Filed With SEC on August 8, 2024)
- Supply and Manufacturing Services Agreement, dated as of March 31, 2023, by and among the Company, WuXi Biologics (Hong Kong) Limited, WuXi Biologics Ireland Limited and WuXi... (Filed With SEC on August 8, 2023)
- Mutual Termination Agreement dated December 22, 2022, by and between Amicus Therapeutics, Inc. and the Trustees of the University of Pennsylvania (Filed With SEC on March 1, 2023)
- Form of Director and Officer Indemnification Agreement (Filed With SEC on December 28, 2022)
- Termination Agreement, dated as of February 23, 2022, by and between ARYA and the Company (Filed With SEC on February 24, 2022)
- Seventh Amendment to the Amended and Restated Research, Collaboration & License Agreement dated September 28, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)
- Sixth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated August 1, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)
- Fifth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated April 6, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)
- Fourth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 23, 2020 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)
- Third Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 3, 2020 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)
- Second Amendment to the Amended and Restated Research, Collaboration & License Agreement dated (Filed With SEC on May 7, 2020)
- First Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 20, 2019 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on May 7, 2020)
- Amended and Restated Research, Collaboration & License Agreement, dated May 28, 2019, by and between Amicus Therapeutics, Inc. and the Trustees of the University of Pennsylvania (Filed With SEC on August 8, 2019)
- Form of Capped Call Transaction Termination Agreement (Filed With SEC on August 8, 2019)
- Form of Call Option Partial Termination Agreement (Filed With SEC on May 9, 2019)
- Research, Collaboration and License Agreement with The Trustees of the University of Pennsylvania dated October 8, 2018 (Filed With SEC on February 28, 2019)
- PLACEMENT AGENCY AGREEMENT (Filed With SEC on February 26, 2010)
- MUTUAL TERMINATION AGREEMENT (Filed With SEC on October 29, 2009)
- License and Collaboration Agreement (Filed With SEC on February 8, 2008)
- EX-10.17: FORM OF DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on March 30, 2007)
- EX-10.18: FORM OF DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on May 17, 2006)
